Cleveland Clinic investigators have launched a novel clinical trial to assess the efficacy of low-intensity focused shockwave therapy and radial wave therapy for treatment of erectile dysfunction or chronic pelvic pain in prostate cancer survivors.
Coordinated Care, Education and Research
Specialists in Cleveland Clinic’s Lupus Clinic are collaborating to reduce the toll lupus takes on an estimated 5 million people worldwide.
A Germline Biomarker Offers Insight Into Treatment Selection for Men With Prostate Cancer
Research study aims to identify biomarkers for predicting response to prostate cancer treatment.
Unravelling the Mysteries of Sepsis and Septic Shock
Cleveland Clinic physician-scientists are working to better understand the differential responses to medications and other supportive therapies in populations with sepsis and septic shock.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Behind Closed Doors: Forensic Nurses Approach Victims With Empathy and Precision
Forensic nurses use specialized training to help patients reclaim their future following a violent or traumatic event.
Delivering Drugs via Drone
Cleveland Clinic plans to use drones to deliver certain medications directly to patients’ homes, starting in 2025. Eventually, the program will expand to include delivery of lab samples, prescription meals, medical and surgical supplies, and items for hospital-at-home services.
Psoriatic Arthritis: Unlocking the Age Factor
The age at which psoriasis first appears can be an important predictor for the transition to psoriatic arthritis.
Program Offers Lifelong Congenital Heart Disease Care
Surgeons discuss the current paradigm for adult congenital heart disease surgery and outline recommendations to strengthen the subspecialty.
Experts Stress Importance of Improved Access to Fentanyl Testing
Psychiatrists say fentanyl test strips can be powerful tool for slowing the scourge of overdoses attributed to tainted street drugs.
Semaglutide Shows Secondary Cardiovascular Prevention Benefits in Patients Without Diabetes
For the first time, a pharmacotherapy for overweight and obesity has reduced cardiovascular events in patients with established cardiovascular disease in the absence of type 2 diabetes.